Acceleron Pharma Inc.
METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
Last updated:
Abstract:
In certain aspects, the present invention provides methods for dosing a patient with an ActRIIb antagonist and methods for managing patients treated with an ActRIIb anatagonist. In certain aspects, the methods involve measuring one or more hematologic parameters in a patient.
Status:
Application
Type:
Utility
Filling date:
27 May 2021
Issue date:
21 Apr 2022